系统性炎症标志物及其与阿尔茨海默病的关联:横截面分析
Abhishek Khatri1, Om Prakash1, Rachna Agarwal2
1Department of Psychiatry, Institute of Human Behaviour and Allied Sciences (IHBAS), New Delhi, India.
Indian journal of psychiatry
|August 5, 2024
概括
系统性炎症标志物,特别是IL-6,在阿尔茨海默氏症痴呆症 (AD) 和血管痴呆症 (VaD) 中升高. 较高的IL-6水平与AD严重程度的增加相关,这表明它在疾病发病过程中发挥了作用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默氏症痴呆症 (AD) 是一种进展性神经退行性疾病.
- 系统性炎症越来越多地与神经退行性疾病的发病有关.
- 互白素-6 (IL-6),C反应蛋白 (CRP) 和白蛋白是主要的系统性炎症标记物.
研究的目的:
- 研究系统性炎症标志物 (IL-6,CRP,白蛋白) 在阿尔茨海默氏症痴呆症 (AD) 发展中的作用.
- 评估这些标志物与阿尔茨海默病的严重程度之间的关联.
- 为了比较AD患者,血管痴呆症 (VaD) 患者和非痴呆症对照 (NDC) 的标记水平.
主要方法:
- 横截面研究设计. 截面研究设计.
- 包括110名年龄在50岁以上的个人:AD患者,VaD患者和NDC.
- 测量血清IL-6,CRP和白蛋白水平;使用痴呆症评分表来确定痴呆症严重程度.
主要成果:
- 与NDC相比,AD和VaD患者的血清IL-6水平显著升高 (P<0.001).
- 两组之间没有发现CRP或白蛋白水平的显著差异.
- 血清IL-6与AD严重程度有显著的正相关性 (r = 0.777);白蛋白有显著的负相关性.
结论:
- 系统性IL-6的升高与AD和VaD有关.
- IL-6水平与阿尔茨海默病的严重程度有显著的相关性,这表明它在病变发生过程中发挥了作用.
- 准IL-6可能为AD提供潜在的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171


